Old Web
English
Sign In
Acemap
>
authorDetail
>
Frank Gary Renshaw
Frank Gary Renshaw
Bayer HealthCare Pharmaceuticals
Cancer
Pathology
Medicine
Copanlisib
advanced cancer
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1b trial of PI3K inhibitor copanlisib (BAY 80-6946) combined with the allosteric-MEK inhibitor refametinib (BAY 86-9766) in patients with advanced cancer.
2014
Journal of Clinical Oncology
Ramesh K. Ramanathan
Daniel D. Von Hoff
F. Eskens
George R. Blumenschein
Donald A. Richards
Frank Gary Renshaw
Prabhu Rajagopalan
Andrea Kelly
C. Pena
Klaus Mross
Show All
Source
Cite
Save
Citations (13)
Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.
2014
Journal of Clinical Oncology
Richard D. Kim
Steven Robert Alberts
Frank Gary Renshaw
Isabelle Genvresse
Stefanie Reif
Jennifer Kaplan
Juneko E. Grilley-Olson
Show All
Source
Cite
Save
Citations (5)
1